Yahoo Web Search

  1. Yahoo Finance Results

  2. The most recent earnings release Pfizer Inc’s (NYSE:PFE) announced in December 2017 suggested that the company gained from a significant tailwind, more than doubling its earnings ...

  3. This could indicate that investors who seek to profit from falling equity prices are not currently targeting PFE. Over the last one-month, outflows of investor capital in ETFs holding PFE totaled ...

    34.49-1.11 (-3.12%)

    at Fri, Mar 23, 2018, 15:01PM EST - U.S. Markets closed

    After Hours 34.51 +0.02 (+0.06%)

    Delayed Quote

    • Open 35.49
    • High 35.50
    • Low 34.44
    • Prev. Close 35.60
    • 52 Wk. High 39.43
    • 52 Wk. Low 31.67
    • P/E 9.81
    • Mkt. Cap 205.17B
  4. Stocks recently featured in the blog include Pfizer Inc. PFE, Verizon Communications Inc. VZ, Altria Group, Inc. MO, Occidental Petroleum Corporation OXY and Community ...

  5. Pfizer Inc. PFE announced a positive outcome from FDA Gastrointestinal Drugs Advisory Committee (GIDAC) meeting that discussed the company’s supplemental New Drug Application ( ...

  6. What's in the Cards for Merck KGaA (MKGAF) in Q4 Earnings?

    Zacks via Yahoo FinanceMar 05 16:11 PM

    Merck KGaA MKGAF is scheduled to report fourth-quarter 2017 results on Mar 8. Merck’s shares have declined 12.8% in the past year against the industry’s gain of 0.2%. Merck’s revenues were driven ...

  7. The Week Ahead In Biotech: Earnings, PDUFA Dates And More

    Benzinga via Yahoo FinanceMar 11 20:58 PM

    NASDAQ: AMGN) received a favorable ruling from a FDA panel that evaluated Blincyto, its treatment candidate for acute lymphoblastic leukemia. The FDA is due to give its verdict on Amgen's Blincyto later this month. Pfizer Inc.

  8. The Senator questioned through letters to CEOs of five big pharma companies — Pfizer PFE, Merck MRK, Johnson & Johnson JNJ, AbbVie ABBV and Abbott Labs ABT — how they plan to use their ...

  9. M&A, Innovation & New Drugs to Drive Pharma Stocks

    Zacks via Yahoo FinanceMar 08 22:00 PM

    Innovation, mergers and acquisitions (M&As), strong results, product approvals and positive data flow should act as catalysts for pharma and biotech stocks. M&As to Accelerate Last year was ...

  10. With the passing of the new tax bill, the corporate tax rate has come down from 35% to 21% which is likely to boosts profit margins. Most big pharma companies discussed their plans to use the ...

  11. FDA panel backs Pfizer's Xeljanz as bowel disease treatment

    Reuters via Yahoo FinanceMar 08 19:53 PM

    Pfizer Inc's Xeljanz should be approved to treat patients with moderate to severe ulcerative colitis, a chronic bowel disease, a U.S. Food and Drug Administration (FDA) advisory ...

  1. Ad
    related to Pfizer, Inc